Results for the second quarter and first half 2011 for MediStim ASA
Sales increased with 4.6 % to MNOK 42.2 for the
second quarter. Operating profit ended at MNOK 8.8
(MNOK 9.5).
For the first half sales increased with
8.8 % to MNOK 84.1 (MNOK 77.3). Operating profit
ended at MNOK 15.3 (MNOK 12.9), an increase of 19.0 %.
There was a 17.7 % growth in procedural sales in the
US for the second quarter and 13.7 % growth in the
first half of 2011. To secure future growth the
commercial organization is strengthened in the US.
Result per share ended at NOK 0.55 for the first half
of 2011 (NOK 0.43).